• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥密克戎和德尔塔变异株导致的 SARS-CoV-2 疫苗突破,美国纽约州。

SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA.

出版信息

Emerg Infect Dis. 2022 Oct;28(10):1990-1998. doi: 10.3201/eid2810.221058. Epub 2022 Sep 1.

DOI:10.3201/eid2810.221058
PMID:36048774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9514330/
Abstract

Recently emerged SARS-CoV-2 variants have greater potential than earlier variants to cause vaccine breakthrough infections. During emergence of the Delta and Omicron variants, a matched case-control analysis used a viral genomic sequence dataset linked with demographic and vaccination information from New York, USA, to examine associations between virus lineage and patient vaccination status, patient age, vaccine type, and time since vaccination. Case-patients were persons infected with the emerging virus lineage, and controls were persons infected with any other virus lineage. Infections in fully vaccinated and boosted persons were significantly associated with the Omicron lineage. Odds of infection with Omicron relative to Delta generally decreased with increasing patient age. A similar pattern was observed with vaccination status during Delta emergence but was not significant. Vaccines offered less protection against Omicron, thereby increasing the number of potential hosts for emerging variants.

摘要

最近出现的 SARS-CoV-2 变异株比早期变异株更有可能导致疫苗突破性感染。在 Delta 和奥密克戎变异株出现期间,一项匹配的病例对照分析使用了一个与美国纽约的人口统计学和疫苗接种信息相关联的病毒基因组序列数据集,以研究病毒谱系与患者疫苗接种状态、患者年龄、疫苗类型和接种后时间之间的关联。病例患者是感染新兴病毒谱系的人,对照者是感染任何其他病毒谱系的人。在完全接种疫苗和加强针接种的人群中,与奥密克戎谱系的感染显著相关。与 Delta 相比,感染奥密克戎的几率通常随患者年龄的增加而降低。在 Delta 出现期间,观察到类似的模式,但不显著。疫苗对奥密克戎的保护作用较低,从而增加了新兴变异株的潜在宿主数量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20d9/9514330/8e88a376e2b8/22-1058-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20d9/9514330/a17666b22ea7/22-1058-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20d9/9514330/8e88a376e2b8/22-1058-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20d9/9514330/a17666b22ea7/22-1058-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20d9/9514330/8e88a376e2b8/22-1058-F2.jpg

相似文献

1
SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA.奥密克戎和德尔塔变异株导致的 SARS-CoV-2 疫苗突破,美国纽约州。
Emerg Infect Dis. 2022 Oct;28(10):1990-1998. doi: 10.3201/eid2810.221058. Epub 2022 Sep 1.
2
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.COVID-19 病例和住院情况按 COVID-19 疫苗接种状况和既往 COVID-19 诊断情况划分-加利福尼亚州和纽约州,2021 年 5 月至 11 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):125-131. doi: 10.15585/mmwr.mm7104e1.
3
Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.瑞士一项多中心队列研究:根据德尔塔和奥密克戎变异株流行期间的基线免疫状态和加强针接种情况,评估卫生专业人员感染 COVID-19 的风险和症状。
PLoS Med. 2022 Nov 7;19(11):e1004125. doi: 10.1371/journal.pmed.1004125. eCollection 2022 Nov.
4
Omicron BA.5 Neutralization among Vaccine-Boosted Persons with Prior Omicron BA.1/BA.2 Infections.奥密克戎 BA.5 对先前感染奥密克戎 BA.1/BA.2 后接种疫苗人群的中和作用。
Emerg Infect Dis. 2022 Dec;28(12):2575-2577. doi: 10.3201/eid2812.221304. Epub 2022 Nov 8.
5
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.mRNA COVID-19 疫苗 3 剂接种与 SARS-CoV-2 奥密克戎和德尔塔变异株引起的有症状感染之间的关联。
JAMA. 2022 Feb 15;327(7):639-651. doi: 10.1001/jama.2022.0470.
6
A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.一种糖基化 RBD 蛋白诱导针对奥密克戎和其他变体的增强型中和抗体,提高对 SARS-CoV-2 感染的保护作用。
J Virol. 2022 Sep 14;96(17):e0011822. doi: 10.1128/jvi.00118-22. Epub 2022 Aug 16.
7
Likelihood of infecting or getting infected with COVID-19 as a function of vaccination status, as investigated with a stochastic model for Aotearoa New Zealand for Delta and Omicron variants.作为奥克兰新新西兰的德尔塔和奥密克戎变体的随机模型调查,接种疫苗状态对感染或感染 COVID-19 的可能性的影响。
N Z Med J. 2022 Apr 1;135:89-100.
8
Comparative Effectiveness of Coronavirus Vaccine in Preventing Breakthrough Infections among Vaccinated Persons Infected with Delta and Alpha Variants.新冠病毒疫苗在预防已接种德尔塔和阿尔法变异株感染者突破性感染中的比较效果。
Emerg Infect Dis. 2022 Feb;28(2):331-337. doi: 10.3201/eid2802.211789. Epub 2021 Dec 7.
9
Shift in SARS-CoV-2 variants of concern from Delta to Omicron was associated with reduced hospitalizations, increased risk of breakthrough infections but lesser disease severity.从德尔塔变异株到奥密克戎变异株的转变与住院人数减少、突破性感染风险增加有关,但疾病严重程度较低。
J Infect Public Health. 2024 Jun;17(6):1100-1107. doi: 10.1016/j.jiph.2024.04.025. Epub 2024 May 3.
10
Delta Infection After Vaccination Elicits Potent Neutralizing Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron.接种疫苗后的德尔塔变异株感染可引发针对严重急性呼吸综合征冠状病毒 2 型奥密克戎的强烈中和免疫。
J Infect Dis. 2022 Nov 1;226(9):1551-1555. doi: 10.1093/infdis/jiac149.

引用本文的文献

1
Beyond the Pandemic Era: Recent Advances and Efficacy of SARS-CoV-2 Vaccines Against Emerging Variants of Concern.后疫情时代:SARS-CoV-2疫苗针对新出现的关注变异株的最新进展与效果
Vaccines (Basel). 2025 Apr 17;13(4):424. doi: 10.3390/vaccines13040424.
2
High-frequency PCR-testing as a powerful approach for SARS-CoV-2 surveillance in the field of critical infrastructure: A longitudinal, retrospective study in a German tertiary care hospital.高频聚合酶链反应检测作为关键基础设施领域中新型冠状病毒2监测的有力方法:德国一家三级护理医院的纵向回顾性研究
PLoS One. 2025 Feb 6;20(2):e0317009. doi: 10.1371/journal.pone.0317009. eCollection 2025.
3

本文引用的文献

1
Routine Surveillance and Vaccination on a University Campus During the Spread of the SARS-CoV-2 Omicron Variant.在 SARS-CoV-2 奥密克戎变异株传播期间对大学校园进行常规监测和疫苗接种。
JAMA Netw Open. 2022 May 2;5(5):e2212906. doi: 10.1001/jamanetworkopen.2022.12906.
2
Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons.奥密克戎变异株的快速出现与接种者中相对于德尔塔的感染优势有关。
Med. 2022 May 13;3(5):325-334.e4. doi: 10.1016/j.medj.2022.03.010. Epub 2022 Apr 6.
3
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
The Scabbard of Excalibur: An Allegory on the Role of an Efficient and Effective Healthcare System under Universal Health Coverage during the Pandemic Response.
王者之剑的剑鞘:关于全民健康覆盖下高效且有效的医疗体系在应对大流行期间作用的一则寓言
Healthcare (Basel). 2024 May 9;12(10):979. doi: 10.3390/healthcare12100979.
4
Evaluation of SARS-CoV-2 anti-Spike antibody levels and breakthrough infection risk among vaccinated adults in North Lebanon.黎巴嫩北部接种疫苗成年人中 SARS-CoV-2 刺突蛋白抗体水平和突破性感染风险的评估。
PLoS One. 2024 May 9;19(5):e0302579. doi: 10.1371/journal.pone.0302579. eCollection 2024.
5
Multivalent and Sequential Heterologous Spike Protein Vaccinations Effectively Induce Protective Humoral Immunity against SARS-CoV-2 Variants.多价和序贯异源刺突蛋白疫苗接种可有效诱导针对SARS-CoV-2变异株的保护性体液免疫。
Vaccines (Basel). 2024 Mar 27;12(4):362. doi: 10.3390/vaccines12040362.
6
Bioengineered amyloid peptide for rapid screening of inhibitors against main protease of SARS-CoV-2.用于快速筛选针对 SARS-CoV-2 主蛋白酶抑制剂的生物工程淀粉样肽。
Nat Commun. 2024 Mar 7;15(1):2108. doi: 10.1038/s41467-024-46296-7.
7
Community Level Correlates of COVID-19 Booster Vaccine Hesitancy in the United States: A Cross-Sectional Analysis.美国新冠病毒加强疫苗接种犹豫的社区层面相关因素:一项横断面分析
Vaccines (Basel). 2024 Feb 6;12(2):167. doi: 10.3390/vaccines12020167.
8
The Impact of SARS-CoV-2 Immune Status and Societal Restrictions in Controlling COVID-19 across the World.严重急性呼吸综合征冠状病毒2型免疫状态和社会限制措施对全球控制2019冠状病毒病的影响。
Vaccines (Basel). 2023 Aug 23;11(9):1407. doi: 10.3390/vaccines11091407.
9
Impacting factors and sources of perceived stress by home-quarantined residents in Shanghai during COVID-19 epidemic.上海新冠疫情期间居家隔离居民感知压力的影响因素及来源。
BMC Public Health. 2023 Apr 28;23(1):780. doi: 10.1186/s12889-023-15701-z.
10
Effect of COVID-19 Vaccination on the In-Hospital Prognosis of Patients Admitted during Delta and Omicron Waves in Italy.2019年冠状病毒病疫苗接种对意大利德尔塔和奥密克戎毒株流行期间住院患者院内预后的影响
Vaccines (Basel). 2023 Feb 6;11(2):373. doi: 10.3390/vaccines11020373.
比较分析英国住院和死亡风险与 SARS-CoV-2 奥密克戎(B.1.1.529)和德尔塔(B.1.617.2)变异株的关系:一项队列研究。
Lancet. 2022 Apr 2;399(10332):1303-1312. doi: 10.1016/S0140-6736(22)00462-7. Epub 2022 Mar 16.
4
Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities - surveillance results from southern Sweden, July 2021 to January 2022.与疫苗接种状态、性别、年龄和合并症相关的 Delta 和奥密克戎变异株导致 COVID-19 重症的风险 - 2021 年 7 月至 2022 年 1 月瑞典南部的监测结果。
Euro Surveill. 2022 Mar;27(9). doi: 10.2807/1560-7917.ES.2022.27.9.2200121.
5
Homologous and Heterologous Covid-19 Booster Vaccinations.同源和异源 COVID-19 加强针接种。
N Engl J Med. 2022 Mar 17;386(11):1046-1057. doi: 10.1056/NEJMoa2116414. Epub 2022 Jan 26.
6
Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant.新冠病毒德尔塔变异株引发的大型溯源清晰的暴发中的病毒感染和传播。
Nat Commun. 2022 Jan 24;13(1):460. doi: 10.1038/s41467-022-28089-y.
7
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.mRNA COVID-19 疫苗 3 剂接种与 SARS-CoV-2 奥密克戎和德尔塔变异株引起的有症状感染之间的关联。
JAMA. 2022 Feb 15;327(7):639-651. doi: 10.1001/jama.2022.0470.
8
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic.奥密克戎变异株对抗体介导的中和作用具有高度抗性:对控制 COVID-19 大流行的影响。
Cell. 2022 Feb 3;185(3):447-456.e11. doi: 10.1016/j.cell.2021.12.032. Epub 2021 Dec 24.
9
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2.奥密克戎变异株对 SARS-CoV-2 表现出明显的抗体逃逸。
Nature. 2022 Feb;602(7898):676-681. doi: 10.1038/s41586-021-04388-0. Epub 2021 Dec 23.
10
Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance.奥密克戎变异株(B.1.1.529):传染性、疫苗突破和抗体耐药性。
J Chem Inf Model. 2022 Jan 24;62(2):412-422. doi: 10.1021/acs.jcim.1c01451. Epub 2022 Jan 6.